A Scalable Synthesis of an Azabicyclooctanyl Derivative, a Novel DPP-4 Inhibitor

被引:23
|
作者
Fei, Zhongbo [2 ]
Wu, Quanbing [2 ]
Zhang, Fei [2 ]
Cao, Yudong [2 ]
Liu, Chuanqin [2 ]
Shieh, Wen-Chung [1 ]
Xue, Song [1 ]
McKenna, Joe [1 ]
Prasad, Kapa [1 ]
Prashad, Mahavir [1 ]
Baeschlin, Daniel [3 ]
Namoto, Kenji [3 ]
机构
[1] Novartis Pharmaceut, Chem & Analyt Dev, E Hanover, NJ 07936 USA
[2] Suzhou Novartis Pharma Technol Co Ltd, Chem & Analyt Dev, Changshu 215537, Jiangsu, Peoples R China
[3] Novartis Inst Biomed Res, Ctr Prote Chem, CH-4002 Basel, Switzerland
来源
JOURNAL OF ORGANIC CHEMISTRY | 2008年 / 73卷 / 22期
关键词
D O I
10.1021/jo801830x
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
A practical synthetic strategy to a chiral azabicycclooctanyl derivative (1), a potent DPP-4 inhibitor, starting from a commercially available nortropine is described. The stereogenic center of 1 was established employing a modified protocol of Ellman's diastereoselective addition of a benzylic nucleophile to tert-butanesulfinimme. Other key steps include Corey-Chaykovsky reaction, Meinwald rearrangement, and CDMT-promoted amide bond formation involving a sterically hindered amine 2.
引用
收藏
页码:9016 / 9021
页数:6
相关论文
共 50 条
  • [1] Discovery of new binding elements in DPP-4 inhibition and their applications in novel DPP-4 inhibitor design
    Liang, Gui-Bai
    Qian, Xiaoxia
    Biftu, Tesfaye
    Singh, Suresh
    Gao, Ying-Duo
    Scapin, Giovanna
    Patel, Sangita
    Leiting, Barbara
    Patel, Reshma
    Wuc, Joseph
    Zhang, Xiaoping
    Thornberry, Nancy A.
    Weber, Ann E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (13) : 3706 - 3710
  • [2] Sitagliptin: A DPP-4 Inhibitor
    McDermaid, Karen
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2007, 60 : 21 - 21
  • [3] Asymmetric Synthesis of Highly Functionalized Tetrahydropyran DPP-4 Inhibitor
    Xu, Feng
    Zacuto, Michael J.
    Kohmura, Yoshinori
    Rosen, Jon
    Gibb, Andrew
    Alam, Mahbub
    Scott, Jeremy
    Tschaen, David
    ORGANIC LETTERS, 2014, 16 (20) : 5422 - 5425
  • [4] Synthesis of a novel analogue of DPP-4 inhibitor Alogliptin: Introduction of a spirocyclic moiety on the piperidine ring
    Kodimuthali, Arumugam
    Prasunamba, Padala Lakshmi
    Pal, Manojit
    BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY, 2010, 6
  • [5] Pharmacokinetics and Pharmacodynamics of KR-66223, a Novel DPP-4 Inhibitor
    Song, Jin Sook
    Lee, Kyeong-Ryoon
    Kwon, Hyun Jin
    Dal Rhee, Sang
    Kim, Min Sun
    Choi, Sung Hum
    Lee, Sung-Hack
    Song, Im Sook
    Ahn, Jin Hee
    Ahn, Sung Hoon
    Bae, Myung Ae
    DRUG METABOLISM AND PHARMACOKINETICS, 2012, 27 (02) : 216 - 222
  • [6] Podocyte-Protective Effect of Evogliptin, a Novel DPP-4 Inhibitor
    Kim, Mi-Kyung
    Cheong, Ye-Hwang
    Jung, Il-Hoon
    Park, Hansu
    Lee, Jeongha
    Chae, Yu Na
    Kim, Tae Hyoung
    Yang, Jae Sung
    DIABETES, 2016, 65 : A136 - A136
  • [7] Review on Chemistry, Analysis and Pharmacology of Teneligliptin: A Novel DPP-4 Inhibitor
    Sharma, Sanjay
    Sharma, Raksha
    Hatware, Ketan
    Patil, Kiran
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2020, 20 (12) : 1091 - 1100
  • [8] Design and synthesis of DPP-4 inhibitor for the treatment of type 2 diabetes
    Peng Cho Tang
    Chinese Chemical Letters, 2010, 21 (03) : 253 - 256
  • [9] Design and synthesis of DPP-4 inhibitor for the treatment of type 2 diabetes
    Tang, Peng Cho
    Lin, Zhi Gang
    Wang, Yang
    Yang, Fang Long
    Wang, Qian
    Fu, Jian Hong
    Zhang, Lei
    Gong, Ai Shen
    Luo, Jing Jing
    Dai, Jun
    She, Gao Hong
    Si, Dan Dan
    Feng, Jun
    CHINESE CHEMICAL LETTERS, 2010, 21 (03) : 253 - 256
  • [10] Synthesis and Anti-Diabetic Activity of an 8-Purine Derivative as a Novel DPP-4 Inhibitor in Obese Diabetic Zücker Rats
    Chayah, Meriem
    Luque-Gonzalez, Angelica
    Gomez-Perez, Veronica
    Salagre, Diego
    Al-Shdaifat, Amjad
    Campos, Joaquin Maria
    Conejo-Garcia, Ana
    Agil, Ahmad
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 1133 - 1141